中国儿童呼吸领域真实世界研究结果发布 ——不同治疗模式对儿童下呼吸道感染疗效的登记研究

2019-10-30 MedSci MedSci原创

10月25日下午,《不同治疗模式对儿童下呼吸道感染疗效的登记研究》(RSCLR研究)的初步结果在第二十四届中华医学会儿科年会期间正式发布!

10月25日下午,《不同治疗模式对儿童下呼吸道感染疗效的登记研究》(RSCLR研究)的初步结果在第二十四届中华医学会儿科年会期间正式发布!RSCLR研究首席顾问上海交通大学附属儿童医院陆权教授和主要研究者(PI)重庆医科大学附属儿童医院刘恩梅教授出席发布会,并与前来参会的专家、学者共同见证和探讨中国首个儿童呼吸领域真实世界研究所取得的成果,助力中国儿童呼吸领域合理用药。

陆权 教授       
        

刘恩梅 教授  
  
《柳叶刀》杂志最新数据显示,下呼吸道感染是导致5岁以下儿童死亡的重要原因之一,因此,临床应重视下呼吸道感染的防治。目前,针对我国患儿下呼吸道感染的临床特点、治疗模式及合理用药,尚缺乏大规模真实世界研究数据。因此,开展针对患儿下呼吸道感染的真实世界研究,将有助于了解疾病的特征,治疗模式,为指导临床合理用药提供研究证据支持。

RSCLR研究旨在评估我国下呼吸道感染性疾病患儿的治疗模式、临床征象(咳嗽、咳痰和哮鸣音)改善,包括减轻程度和时间,为相关威廉亚洲博彩公司 的制定提供证据支持。研究共涵盖了全国37家研究中心,4855例患儿的诊疗数据。

儿童肺炎的治疗模式

肺炎是RSCLR研究中最主要的疾病类型,占总体人群的73%。按照2019儿童社区获得性肺炎威廉亚洲博彩公司 的分类,将治疗模式分为病原针对性治疗(抗菌药物或抗病毒药物);对症治疗(解热镇痛类、祛痰止咳类、平喘类等药物);辅助治疗(糖皮质激素、免疫增强剂);中成药。分析显示,研究中以针对病原治疗和对症治疗为基础的治疗模式占60.8%,与威廉亚洲博彩公司 推荐临床路径相吻合。其中,抗菌药和祛痰止咳药是肺炎患儿的主要临床用药。

祛痰止咳药的临床结局及影响因素

研究结果显示,临床使用最多的祛痰止咳药物为氨溴索口服液(36%)和氨溴特罗(26.7%)。在使用祛咳止痰药物治疗7天时,有超过半数轻、中、重度患儿的呼吸道症状均获得临床控制。单因素分析显示,未使用祛痰止咳药是影响患儿转归的危险因素(比值比 0.732,95% CI:0.6~0.893;P=0.002),对症治疗有利于肺炎患儿临床症状转归。在RSCLR研究中不同祛痰止咳药物的临床有效率均超过80%。另外,监护人疾病知识知晓程度、基线咳痰难易程度QS评分及基线哮鸣音QS评分可能是影响祛痰止咳药物疗效的影响因素。安全性数据显示,RSCLR研究中肺炎治疗方案的总体安全性良好,研究中发生的不良反应可能主要与抗菌药物有关。

真实世界研究所产生的证据是上市前临床研究的重要补充,具有重要的现实意义。未来,项目组将继续对研究数据库展开深入挖掘和分析,发现真实世界中治疗模式与威廉亚洲博彩公司 的差异、呼吸道征象转归的影响因素、下呼吸道感染患儿自报结局及相关药物经济学数据等,旨在为规范我国儿科领域下呼吸道感染的治疗提供更坚实的循证医学证据,让williamhill asia 拭目以待。

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1739526, encodeId=e4341e39526d7, content=<a href='/topic/show?id=8041e343504' target=_blank style='color:#2F92EE;'>#研究结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73435, encryptionId=8041e343504, topicName=研究结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbcd34536678, createdName=1249894fm84暂无昵称, createdTime=Wed Nov 27 05:28:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282497, encodeId=857e128249eec, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295249, encodeId=159d12952494a, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486537, encodeId=d386148653eab, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555155, encodeId=af2f155515567, content=<a href='/topic/show?id=b9c0646602d' target=_blank style='color:#2F92EE;'>#治疗模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64660, encryptionId=b9c0646602d, topicName=治疗模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b614593183, createdName=yankaienglish, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032318, encodeId=9ad21032318bb, content=谢谢williamhill asia 提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Oct 30 16:28:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1739526, encodeId=e4341e39526d7, content=<a href='/topic/show?id=8041e343504' target=_blank style='color:#2F92EE;'>#研究结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73435, encryptionId=8041e343504, topicName=研究结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbcd34536678, createdName=1249894fm84暂无昵称, createdTime=Wed Nov 27 05:28:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282497, encodeId=857e128249eec, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295249, encodeId=159d12952494a, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486537, encodeId=d386148653eab, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555155, encodeId=af2f155515567, content=<a href='/topic/show?id=b9c0646602d' target=_blank style='color:#2F92EE;'>#治疗模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64660, encryptionId=b9c0646602d, topicName=治疗模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b614593183, createdName=yankaienglish, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032318, encodeId=9ad21032318bb, content=谢谢williamhill asia 提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Oct 30 16:28:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
    2019-11-01 zhmscau
  3. [GetPortalCommentsPageByObjectIdResponse(id=1739526, encodeId=e4341e39526d7, content=<a href='/topic/show?id=8041e343504' target=_blank style='color:#2F92EE;'>#研究结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73435, encryptionId=8041e343504, topicName=研究结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbcd34536678, createdName=1249894fm84暂无昵称, createdTime=Wed Nov 27 05:28:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282497, encodeId=857e128249eec, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295249, encodeId=159d12952494a, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486537, encodeId=d386148653eab, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555155, encodeId=af2f155515567, content=<a href='/topic/show?id=b9c0646602d' target=_blank style='color:#2F92EE;'>#治疗模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64660, encryptionId=b9c0646602d, topicName=治疗模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b614593183, createdName=yankaienglish, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032318, encodeId=9ad21032318bb, content=谢谢williamhill asia 提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Oct 30 16:28:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1739526, encodeId=e4341e39526d7, content=<a href='/topic/show?id=8041e343504' target=_blank style='color:#2F92EE;'>#研究结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73435, encryptionId=8041e343504, topicName=研究结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbcd34536678, createdName=1249894fm84暂无昵称, createdTime=Wed Nov 27 05:28:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282497, encodeId=857e128249eec, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295249, encodeId=159d12952494a, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486537, encodeId=d386148653eab, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555155, encodeId=af2f155515567, content=<a href='/topic/show?id=b9c0646602d' target=_blank style='color:#2F92EE;'>#治疗模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64660, encryptionId=b9c0646602d, topicName=治疗模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b614593183, createdName=yankaienglish, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032318, encodeId=9ad21032318bb, content=谢谢williamhill asia 提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Oct 30 16:28:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1739526, encodeId=e4341e39526d7, content=<a href='/topic/show?id=8041e343504' target=_blank style='color:#2F92EE;'>#研究结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73435, encryptionId=8041e343504, topicName=研究结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbcd34536678, createdName=1249894fm84暂无昵称, createdTime=Wed Nov 27 05:28:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282497, encodeId=857e128249eec, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295249, encodeId=159d12952494a, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486537, encodeId=d386148653eab, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555155, encodeId=af2f155515567, content=<a href='/topic/show?id=b9c0646602d' target=_blank style='color:#2F92EE;'>#治疗模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64660, encryptionId=b9c0646602d, topicName=治疗模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b614593183, createdName=yankaienglish, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032318, encodeId=9ad21032318bb, content=谢谢williamhill asia 提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Oct 30 16:28:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1739526, encodeId=e4341e39526d7, content=<a href='/topic/show?id=8041e343504' target=_blank style='color:#2F92EE;'>#研究结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73435, encryptionId=8041e343504, topicName=研究结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbcd34536678, createdName=1249894fm84暂无昵称, createdTime=Wed Nov 27 05:28:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282497, encodeId=857e128249eec, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295249, encodeId=159d12952494a, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486537, encodeId=d386148653eab, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555155, encodeId=af2f155515567, content=<a href='/topic/show?id=b9c0646602d' target=_blank style='color:#2F92EE;'>#治疗模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64660, encryptionId=b9c0646602d, topicName=治疗模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b614593183, createdName=yankaienglish, createdTime=Fri Nov 01 04:28:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032318, encodeId=9ad21032318bb, content=谢谢williamhill asia 提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Oct 30 16:28:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
    2019-10-30 内科新手

    谢谢williamhill asia 提供这么好的信息,学到很多

    0

相关威廉亚洲官网

儿科医生,口吃是发育疾病还是心理疾病?

很多宝妈发现自己宝宝在2~3岁这个阶段出现了“口吃”的问题,比如宝宝在和宝妈说话的时候常常重复某个字词或是说话前要犹豫上一段时间,急匆匆的就带孩子去医院看,怕影响孩子语言能力的发育,那么儿童口吃到底是发育疾病还是心理疾病呢?

JAMA Oncology: BRCA2或为非霍奇金淋巴瘤关键基因

BRCA2或为非霍奇金淋巴瘤关键基因7月25日JAMA Oncology在线发表一篇研究,研究者们对1380名小儿或青少年淋巴瘤幸存者进行了全基因组测序,并将结果与基因组聚集数据库中无癌成人的结果进行了比较,发现BRCA2突变在非霍奇金淋巴瘤的儿童幸存者中的发生率是对照组的5倍。在普通人群中,BRCA2突变的发生频率通常仅有千分之一。这意味着BRCA2突变相关癌症又添一员。虽然这看起来似乎是个

复旦儿科医联体呼吸协作网揭牌,推进儿科分级诊疗

如今,肺炎仍是五岁以下儿童死亡的三大原因之一,是危害儿童健康的主要疾病。而不同级别医疗机构的医生同质化水平差,使得孩子罹患呼吸系统疾病时,家长第一时间总是寄望三甲儿童专科医院。如何改变这样的状况,成为当下上海医疗界思考的问题。11日,由复旦大学附属儿科医院呼吸科牵头,包括上海市南片区的12家综合医院和29家社区卫生服务中心正式成立了复旦儿科医联体呼吸协作网。复旦大学附属儿科医院呼吸科主任王立波教授

JAMA:5岁前谷物摄入量与高遗传风险儿童乳糜泻风险

研究发现,5岁前谷物摄入量与高遗传风险儿童乳糜泻风险相关

门诊儿科患者通过鼻腔给予右美托咪定的药代动力学及镇静作用研究

williamhill asia 的目的是研究通过鼻腔内给予右美托咪定作为小儿磁共振检查镇静剂的药代动力学和镇静作用。

宝宝长的矮就是生长发育迟缓吗?看看儿科医生怎么说

在如今物质丰富的社会,吃得好、吃得饱已经不是问题,然而有些孩子的身高增长却未能如家长所愿。有些家长一旦发现宝贝比同龄孩子矮了,就害怕孩子是不是发育迟缓,输在了起跑线上。那么孩子长得矮就是发育迟缓吗?